Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | |
| Cash Flows From Operating Activities | |
| Net Income | -4,964 |
| Depreciation Amortization | 424 |
| Accounts payable and accrued liabilities | 16 |
| Other Working Capital | -82 |
| Other Operating Activity | -3 |
| Operating Cash Flow | $-4,608 |
| Cash Flows From Investing Activities | |
| PPE Investments | -292 |
| Purchase Sale Intangibles | -429 |
| Other Investing Activity | -429 |
| Investing Cash Flow | $-722 |
| Cash Flows From Financing Activities | |
| Debt Repayment | -6 |
| Common Stock Issued | 59 |
| Other Financing Activity | 4 |
| Financing Cash Flow | $57 |
| Beginning Cash Position | 8,826 |
| End Cash Position | 3,553 |
| Net Cash Flow | $-5,273 |
| Free Cash Flow | |
| Operating Cash Flow | -4,608 |
| Capital Expenditure | -292 |
| Free Cash Flow | -4,900 |